Siebold S.N. de Graaf

Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12

Christine J. Harrison, Robert K. Hills, Anthony V. Moorman et al. · Journal of Clinical Oncology · 2010 · 306 citations

Life Sciences, Hematology, Pediatrics +17

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

B Gibson, Keith Wheatley, Ian Hann et al. · Leukemia · 2005 · 304 citations

Medicine, Hematology, Pediatrics +8

Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial

Brenda Gibson, David Webb, Andrew Howman et al. · British Journal of Haematology · 2011 · 205 citations

Medicine, Oncology, Pediatrics +17

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

Iris H.I.M. Hollink, C. Michel Zwaan, Martin Zimmermann et al. · Leukemia · 2008 · 162 citations

Medicine, Hematology, Oncology +16

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

Vincent H. J. van der Velden, A van der Sluijs-Geling, B Gibson et al. · Leukemia · 2010 · 145 citations

Medicine, Hematology, Oncology +17